Nivolumab for Colorectal Cancer User Reviews

Brand names: Opdivo

Nivolumab has an average rating of 4.8 out of 10 from a total of 4 reviews for the treatment of Colorectal Cancer. 50% of reviewers reported a positive experience, while 50% reported a negative experience.

Nivolumab rating summary

4.8/10 average rating

4 ratings from 5 user reviews.

Compare all 53 medications used in the treatment of Colorectal Cancer.

10		0%
9		25%
8		25%
7		0%
6		0%
5		0%
4		0%
3		0%
2		0%
1		50%

ilove...
January 9, 2018

Opdivo (nivolumab) "I have small intestines cancer/stage 4 .I have been on opdivo for 1 full year because I could not tolerate chemo any more. It took 9 months for pain relief and 4 months ago, my CT scan showed that my tumors have shrunk 30 percent. Opdivo has saved my life ! I have only diarrhea as a side effect. I am so grateful that my dr. put me on this as I would not be alive . I have gained 20 lbs and don't feel as if i have cancer. I can't wait to get my next CT scan"

Was this helpful?Yes No

9 Report

Sherry
Taken for 1 to 6 months
July 26, 2021

Opdivo (nivolumab) "Was out of remission and had to take radiation and Opdivo . The cancer was resolved by the radiation treatment not the Opdivo. What the Opdivo did was damaged not only my thyroid but my salivary glands as well and caused blisters in my mouth."

1 / 10

Was this helpful?Yes No

0 Report

Robyn
Taken for 2 to 5 years
September 27, 2021

Opdivo (nivolumab) "I have been dealing with abdominal tumor growth for 15 years. I started Opdivo three years ago after two scans that showed tumor growth. It kept my tumors from growing for 2.5 years. I had almost no side effects. Just occasional loose stools and occasional rashes that were not itchy and went away in a few days. I started taking it every 2 weeks and then moved to once a month. I was in and out of labs and infusion in 1.5 hours so I never needed to miss work."

8 / 10

Was this helpful?Yes No

0 Report

Frequently asked questions

Anonymous
Taken for 1 to 6 months
January 18, 2022

Opdivo (nivolumab) "My brother was in the clinical trials. His tumor had gotten bigger after Opdivo treatments, so he was dropped from the clinical trials. Months later, my brother's tumors "APPEARED" to have shrunk, so he was immediately put back into the trials, so his data could be counted."

1 / 10

Was this helpful?Yes No

0 Report

Richard
March 9, 2023

Opdivo (nivolumab) "Cancer has decreased from 26mm to 8 mm. Experienced diarrhea daily, need to drink lots of water, occasional dizziness, trouble focusing on written words on computer, fatigue."

9 / 10

Was this helpful?Yes No

2 Report

Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.